Montelin, Myca .
HRN: 24-08-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFTRIAXONE 1G (VIAL)
11/14/2023
11/20/2023
IV DRIP
750mg
Q24h
BFC, PCAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes